First experience with the application of 7-methoxytacrine to psychiatric patients.
Zapletálek
M
M
Dept. of Psychiatry, Hradec Králové.
Hanus
H
H
Fusek
J
J
Hrdina
V
V
D000328:Adult; D000609:Aminoacridines / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D013619:Tacrine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000609:Aminoacridines; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D013619:Tacrine; C016222:7-methoxytacrine